Passage Bio, Inc. operates as a genetic medicines company. It focuses on developing transformative therapies for rare, monogenic central nervous system disorders with limited or no approved treatment options. The company assembles a portfolio of genetic medicine products, which includes PBGM01 for the treatment of GM1, PBFT02 for the treatment of FTD and PBKR03 for the treatment of Krabbe disease. Passage Bio was founded by Stephen P. Squinto, Tadataka Yamada, David A. Socks, Aditya Kohli, and James M. Wilson in July 2017 and is headquartered in Philadelphia, PA. |  |
|
|
| Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
| Lynx1 Capital Management LP | 10% Owner | Sep 12 '25 | Buy | 6.99 | 19,783 | 138,299 | 611,804 | Sep 15 08:05 PM | | Lynx1 Capital Management LP | 10% Owner | Sep 15 '25 | Buy | 6.99 | 11,900 | 83,175 | 623,704 | Sep 15 08:05 PM | | Lynx1 Capital Management LP | 10% Owner | Sep 11 '25 | Buy | 6.96 | 325 | 2,261 | 592,021 | Sep 15 08:05 PM | | Lynx1 Capital Management LP | 10% Owner | Jul 24 '25 | Buy | 5.71 | 66,423 | 379,455 | 591,696 | Jul 24 06:12 PM | | Lynx1 Capital Management LP | 10% Owner | Jul 23 '25 | Buy | 5.74 | 49,302 | 283,033 | 525,273 | Jul 24 06:12 PM | | Lynx1 Capital Management LP | 10% Owner | Jul 22 '25 | Buy | 5.44 | 13,123 | 71,338 | 475,971 | Jul 24 06:12 PM | | OrbiMed Private Investments VI | Stockholder | Jul 21 '25 | Proposed Sale | 5.56 | 132,645 | 737,506 | | Jul 21 05:33 PM | | OrbiMed Private Investments VI | Stockholder | Jul 15 '25 | Proposed Sale | 6.79 | 53,293 | 361,859 | | Jul 15 08:17 PM | | OrbiMed Private Investments VI | Stockholder | Jul 07 '25 | Proposed Sale | 0.43 | 259,000 | 112,147 | | Jul 07 06:02 PM | | ORBIMED ADVISORS LLC | 10% Owner | Jun 24 '25 | Sale | 0.35 | 231,600 | 81,060 | 6,418,400 | Jun 26 05:10 PM | | ORBIMED ADVISORS LLC | 10% Owner | Jun 26 '25 | Sale | 0.33 | 213,257 | 70,375 | 6,066,343 | Jun 26 05:10 PM | | ORBIMED ADVISORS LLC | 10% Owner | Jun 25 '25 | Sale | 0.33 | 138,800 | 45,804 | 6,279,600 | Jun 26 05:10 PM | | OrbiMed Private Investments VI | Stockholder | Jun 24 '25 | Proposed Sale | 0.35 | 1,076,120 | 378,364 | | Jun 24 06:48 PM | | ORBIMED ADVISORS LLC | 10% Owner | Apr 23 '25 | Sale | 0.34 | 89,328 | 30,372 | 6,718,195 | Apr 24 05:38 PM | | ORBIMED ADVISORS LLC | 10% Owner | Apr 22 '25 | Sale | 0.34 | 78,049 | 26,537 | 6,807,523 | Apr 24 05:38 PM | | ORBIMED ADVISORS LLC | 10% Owner | Apr 24 '25 | Sale | 0.32 | 68,195 | 21,822 | 6,650,000 | Apr 24 05:38 PM | | ORBIMED ADVISORS LLC | 10% Owner | Apr 17 '25 | Sale | 0.33 | 77,090 | 25,440 | 6,885,572 | Apr 17 06:10 PM | | ORBIMED ADVISORS LLC | 10% Owner | Apr 16 '25 | Sale | 0.33 | 61,638 | 20,341 | 6,962,662 | Apr 17 06:10 PM | | ORBIMED ADVISORS LLC | 10% Owner | Apr 15 '25 | Sale | 0.38 | 10,326 | 3,924 | 7,024,300 | Apr 17 06:10 PM | | OrbiMed Private Investments VI | Stockholder | Apr 15 '25 | Proposed Sale | 0.38 | 787,179 | 301,490 | | Apr 15 05:40 PM | | Borthwick Kathleen | CFO | Feb 11 '25 | Sale | 0.53 | 3,183 | 1,686 | 41,283 | Feb 12 04:21 PM | | ORBIMED ADVISORS LLC | 10% Owner | Jan 10 '25 | Sale | 0.66 | 126,209 | 83,298 | 7,131,636 | Jan 14 05:17 PM | | ORBIMED ADVISORS LLC | 10% Owner | Jan 14 '25 | Sale | 0.60 | 79,024 | 47,414 | 7,034,626 | Jan 14 05:17 PM | | ORBIMED ADVISORS LLC | 10% Owner | Jan 13 '25 | Sale | 0.64 | 17,986 | 11,511 | 7,113,650 | Jan 14 05:17 PM | | ORBIMED ADVISORS LLC | 10% Owner | Jan 08 '25 | Sale | 0.68 | 75,007 | 51,005 | 7,257,845 | Jan 08 06:09 PM | | ORBIMED ADVISORS LLC | 10% Owner | Jan 07 '25 | Sale | 0.71 | 52,536 | 37,301 | 7,332,852 | Jan 08 06:09 PM | | ORBIMED ADVISORS LLC | 10% Owner | Jan 06 '25 | Sale | 0.77 | 19,481 | 15,000 | 7,385,388 | Jan 08 06:09 PM | | OrbiMed Private Investments VI | Stockholder | Jan 06 '25 | Proposed Sale | 0.83 | 1,140,740 | 945,673 | | Jan 06 04:57 PM | | Lynx1 Capital Management LP | 10% Owner | Dec 27 '24 | Buy | 0.65 | 373,645 | 241,038 | 9,256,953 | Dec 31 04:05 PM | | ORBIMED ADVISORS LLC | 10% Owner | Dec 20 '24 | Sale | 0.60 | 230,321 | 138,193 | 7,404,869 | Dec 26 04:34 PM | | ORBIMED ADVISORS LLC | 10% Owner | Dec 10 '24 | Sale | 0.80 | 8,015 | 6,412 | 7,635,270 | Dec 11 05:32 PM | | ORBIMED ADVISORS LLC | 10% Owner | Dec 11 '24 | Sale | 0.80 | 80 | 64 | 7,635,190 | Dec 11 05:32 PM |
|
